Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0282013 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Suresh Ponnuvel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Virology, Christian Medical College, Vellore, India. Hauptthemen laut MEDLINE: Antiviral Agents, Hepatitis C, Chronic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Christian Medical College, Department of Clinical Virology.
Abstract (Originalsprache)
Background
In the economy of therapeutic monitoring, an affordable viral marker is essential in the era of direct-acting antivirals (DAAs). We elucidated the kinetics of HCVcAg to delineate its precise role in monitoring therapeutic response.
Methods
In this longitudinal study, 3208 patients were tested for HCV RNA. A total of 423 patients were started on DAAs. Treatment response and kinetics of HCVcAg/RNA were assessed in treatment-naïve (n = 383) and previously treated (n = 40) patients with follow-up for 2 years.
Results
After the initiation of DAAs, the rate of relapse was significantly higher in the previously treated group than naive group [12.5% (5/40) Vs 2% (7/383), p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Virology, Christian Medical College, Vellore, India.
- Department of Integrative Biology, Vellore Institute of Technology, Vellore, India.
- Department of Hepatology, Christian Medical College, Vellore, India.
- Department of Biostatistics, Christian Medical College, Vellore, India.
ORCID-Profile: Suresh Ponnuvel, Gnanadurai John Fletcher
Förderung
- Christian Medical College
- Department of Clinical Virology
Zitieren
APA
Ponnuvel, S., Prakash, A., Steve, R. J., Doss, G. P., Goel, A., Zachariah, U. G., Eapen, C. E., Rebekah, G., Kannangai, R., Fletcher, G. J., & Abraham, P. (2023). Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs. PLOS ONE. https://doi.org/10.1371/journal.pone.0282013
Vancouver
Ponnuvel S, Prakash A, Steve RJ, Doss GP, Goel A, Zachariah UG, et al. Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs. PLOS ONE. 2023. doi:10.1371/journal.pone.0282013
BibTeX
@article{Ponnuvel2023,
author = {Ponnuvel, Suresh and Prakash, Arul and Steve, Runal John and Doss, George Priya and Goel, Ashish and Zachariah, Uday George and Eapen, Chundamannil Eapen and Rebekah, Grace and Kannangai, Rajesh and Fletcher, Gnanadurai John and Abraham, Priya},
title = {Longitudinal assessment of HCV core antigen kinetics to monitor therapeutic response in the age of DAAs},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0282013}
}
EUVIMED